NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.
NLS Pharma has raised €4.9M across 2 funding rounds from 1 investor, most recently a round in Apr 2025. Based in Stans, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-04-09 | Other | €2.7M | — | View deal → |
| 2021-09-28 | Other | €2.1M | YA | View deal → |
